- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
AstraZeneca - number of animals used for research purposes 2006-2018
AstraZeneca - number of animals used for research purposes 2006-2018
Number of animals used for research purposes by pharmaceutical company AstraZeneca from 2006 to 2018*
This statistic shows the number of animals that were used by pharmaceutical company AstraZeneca for research purposes from 2006 to 2018. In 2010, around 408,000 animals were used by AstraZeneca for research purposes.
Number of animals used for research purposes by pharmaceutical company AstraZeneca from 2006 to 2018*
Loading statistic...
| Number of animals | |
|---|---|
| 2018 | 121,823 |
| 2017 | 131,615 |
| 2016 | 193,451 |
| 2015 | 182,055 |
| 2014 | 194,162 |
| 2013 | 260,930 |
| 2012 | 304,751 |
| 2011 | 381,000 |
| 2010 | 408,000 |
| 2009 | 393,000 |
| 2008 | 347,000 |
| 2007 | 285,000 |
| 2006 | 288,000 |
| Number of animals | |
|---|---|
| 2018 | 121,823 |
| 2017 | 131,615 |
| 2016 | 193,451 |
| 2015 | 182,055 |
| 2014 | 194,162 |
| 2013 | 260,930 |
| 2012 | 304,751 |
| 2011 | 381,000 |
| 2010 | 408,000 |
| 2009 | 393,000 |
| 2008 | 347,000 |
| 2007 | 285,000 |
| 2006 | 288,000 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the number of animals that were used by pharmaceutical company AstraZeneca for research purposes from 2006 to 2018. In 2010, around 408,000 animals were used by AstraZeneca for research purposes.
Show more- Show sources information
- Show publisher information
- Release date
- March 2019
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
-
* Excluding animals used by external CROs on AstraZeneca's behalf.
This statistic was assembled from several annual reports.
Source
- Show sources information
- Show publisher information
- Release date
- March 2019
More information
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
-
* Excluding animals used by external CROs on AstraZeneca's behalf.
This statistic was assembled from several annual reports.
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2015*European Union: share of GDP expenditure on research and development 2000-2015
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)Research and development in European pharmaceutical industry by country 2016
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2003 and 2017Yearly growth rate of R&D spending in pharmaceutical industry 2003-2017
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2015
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)Leading European pharmaceutical & biotechnology companies ranked by market value 2015
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)Leading European pharmaceutical companies by R&D spending 2015
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)Leading European pharmaceutical companies by R&D investment 2014
- Pharmaceutical production value of EFPIA members from 1990 to 2017 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2017
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2017 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2017
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2016Employment in European pharmaceutical industry by country 2016
- Total pharmaceutical employment in EFPIA countries from 1990 to 2017Employment in EFPIA pharmaceutical industry 1990-2017
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2017Italy: number of employees in the pharmaceutical industry 2000-2017
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- AstraZeneca's employees by region 2018
- AstraZeneca's revenue 2013-2018 by region
- AstraZeneca's R&D expenditure as a percentage of revenue 2006-2018
- AstraZeneca's revenue by therapeutic area 2015-2018
- AstraZeneca's operating profit 2006-2018
- AstraZeneca's revenue from top product Seroquel 2006-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2018
- AstraZeneca's expenditure on research and development 2006-2018
- Animals used in research in the United States 2008-2017
- Animals used in research in the United States in 2017, by species
- AstraZeneca - ad spend in the U.S. 2014, by medium
- Worldwide Rx drug sales excluding generics and orphan drugs 2002-2024
- Orphan vs. non-orphan drugs median cost per patient per year 2013-2017
- Peak sales per new pharmaceutical asset 2010-2018
- Pricing of orphan drugs across three countries on annual basis 2016
- Changes in forward P/E ratios in the pharmaceutical industry 2015-2016
- Global veterinary diagnostics market size 2023 forecast
- Pharmaceutical sector expenditure forecast worldwide by country 2060
Studies
- Biotechnology Industry in Europe
- Pharmaceutical industry in Italy
- Animal testing in the United Kingdom
- Putting the Science back into Life Sciences
- Unleashing Pharma from the R&D Value Chain
- 2018 PhRMA Annual Membership Survey
- The 2018 Genentech Oncology Trend Report
- Life Sciences Outlook United States 2017
- Global Participation in Clinical Trials Report 2015-2016
- The Changing Face of Global Clinical Trials
- The 2017 Genentech Oncology Trend Report
- Public Attitudes to Animal Research in 2016
- 2015 Global life sciences outlook
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- PhRMA 2014 Biopharmaceutical Research Industry Profile
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2015*
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2003 and 2017
- Market share of generics in selected European countries as of 2016
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2017 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2017 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2016
- Total pharmaceutical employment in EFPIA countries from 1990 to 2017
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2017
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Distribution of employees at AstraZeneca in 2018, by region
- AstraZeneca's revenue from 2013 to 2018, by region (in million U.S. dollars)
- AstraZeneca's research & development expenditure as a percentage of total revenue from 2006 to 2018
- AstraZeneca's revenue from 2015 to 2018, by therapy area (in million U.S. dollars)
- AstraZeneca's operating profit from 2006 to 2018 (in million U.S. dollars)
- AstraZeneca's revenue from top product Seroquel from 2006 to 2018 (in million U.S. dollars)*
- AstraZeneca's revenue from top product Pulmicort from 2006 to 2018 (in million U.S. dollars)
- AstraZeneca's expenditure on research and development from 2006 to 2018 (in million U.S. dollars)
- Number of animals used in research in the United States from 2008 to 2017
- Number of animals used in research in the United States in 2017, by species
- AstraZeneca's direct-to-consumer (DTC) advertising spending in the United States in 2014, by medium (in million U.S. dollars)
- Prescription drugs sales worldwide excluding generics and orphan drugs from 2002 to 2024 (in billion U.S. dollars)
- Median cost per patient per year for orphan and non-orphan drugs from 2013 to 2017 (in U.S. dollars)
- Peak sales for each new pharmaceutical asset from 2010 to 2018, by study cohort (in million U.S. dollars)
- Selected annual-based orphan drug prices compared in UK, U.S., and Australia as of 2016 (in U.S. dollars)*
- Changes in forward price to earnings ratios in the global pharmaceutical industry between year-end 2015 and 2016
- Global veterinary diagnostics market in 2018 and a forecast for 2023 (in billion U.S. dollars)*
- Worldwide forecast of pharmaceutical expenditures in 2060, by country (in million U.S. dollars)*
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.